AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Zeo Energy Corp.

$0.23 -$0.94 (-80.51%)
NASDAQ · 15 Sep 2026 16:43 UTC
Previous Close
$0.24
Day Range
$0.22$0.24
Year Range
$0.19$2.06
Market Cap
8.07M
AVG Volume
978.04K
Trailing/Forward PE
-0.56/-
PEG ratio
-0.02
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
NASDAQUS
Revenue (USD)
010M20M30M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ZEO Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q216.17M
26 Q113.18M
25 Q418.57M
25 Q323.9M
25 Q218.1M
25 Q18.78M
24 Q418.65M
24 Q319.66M
24 Q214.71M
24 Q120.14M
Net Income (USD)
-8M-6M-4M-2M02M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ZEO Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-2.34M
26 Q1-3.51M
25 Q4-2.01M
25 Q3-3.23M
25 Q2-2.42M
25 Q1-6.36M
24 Q4-435.35K
24 Q3-424.26K
24 Q2167.24K
24 Q1-1.53M
Operating Income (USD)
-15M-10M-5M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ZEO Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2-2.99M
26 Q1-4.77M
25 Q4-2.19M
25 Q3-1.98M
25 Q2-2.85M
25 Q1-13.51M
24 Q4-1.14M
24 Q3-2.98M
24 Q2-2.2M
24 Q1-4.05M
EBITDA (USD)
-10M-7.5M-5M-2.5M02.5M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ZEO EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2-2.37M
26 Q1-3.68M
25 Q4-1.61M
25 Q3-1.44M
25 Q2321.95K
25 Q1-7.86M
24 Q41.68M
24 Q3-2.21M
24 Q2-859.91K
24 Q1-3.73M
Cash Flows (USD)
-15M-10M-5M05M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ZEO Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2-662.42K
26 Q1-1.06M
25 Q42.27M
25 Q3-6.82M
25 Q2-2.72M
25 Q1-2.64M
24 Q43.39M
24 Q3207.98K
24 Q2-2.3M
24 Q1-10.38M
EPS (USD)
-0.6-0.4-0.2-00.224 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ZEO EPS (USD) by quarter
PeriodEPS (USD)
26 Q2-0.09
26 Q1-0.11
25 Q4-0.08
25 Q3-0.12
25 Q2-0.11
25 Q1-0.48
24 Q4-0.04
24 Q3-0.04
24 Q20.02
24 Q1-0.11
Expenses (USD)
-5M05M10M15M20MSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ZEO Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q210.57M
26 Q19.49M
25 Q411.74M
25 Q315.81M
25 Q210.93M
25 Q112.98M
24 Q49.23M
24 Q312.31M
24 Q26.23M
24 Q110M
Cash & Debt (USD)
02M4M6M8MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ZEO Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q22.45M
26 Q11.73M
25 Q46.14M
25 Q33.92M
25 Q268.69K
25 Q12.89M
24 Q45.63M
24 Q34.33M
24 Q25.34M
24 Q17.73M
Debt ratios
-6-4-202424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ZEO Debt ratios by quarter
PeriodDebt ratios
26 Q20.1
26 Q10.04
25 Q40.45
25 Q3-0.04
25 Q2-0.57
25 Q1-0.21
24 Q40.11
24 Q30.19
24 Q22.52
24 Q1-4.91
Margins
0%20%40%60%80%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ZEO Margins by quarter
PeriodMargins
26 Q247.15%
26 Q134.31%
25 Q451.86%
25 Q357.93%
25 Q259.76%
25 Q145.47%
24 Q461.3%
24 Q350.21%
24 Q229.81%
24 Q130.7%
Return on Capital
-60%-40%-20%0%20%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ZEO Return on Capital by quarter
PeriodReturn on Capital
26 Q2-25.21%
26 Q1-8.09%
25 Q4-6.63%
25 Q3-7%
25 Q2-18.59%
25 Q1-42.35%
24 Q4-1.01%
24 Q3-2.4%
24 Q20.45%
24 Q1-4.06%
Shares Outstanding
010M20M30M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ZEO Shares Outstanding by quarter
PeriodShares Outstanding
26 Q224.94M
26 Q124.94M
25 Q424.94M
25 Q327.31M
25 Q222.1M
25 Q113.25M
24 Q411.06M
24 Q310.89M
24 Q210.89M
24 Q110.89M
Book Value Per Share (USD)
0123424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ZEO Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q20.37
26 Q11.74
25 Q41.21
25 Q31.69
25 Q20.59
25 Q11.13
24 Q43.88
24 Q31.62
24 Q23.39
24 Q13.47
Total Assets (USD)
020M40M60M80M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ZEO Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q255.97M
26 Q156.53M
25 Q456.93M
25 Q358.5M
25 Q246.23M
25 Q147.45M
24 Q461.4M
24 Q347.1M
24 Q249.07M
24 Q151.59M
Employee Count
050100150200202320242025
ZEO Employee Count by quarter
PeriodEmployee Count
2025190
2024190
2023190
PE Ratio
0102030med 13.36May 23Aug 23Nov 23Feb 24May 24Aug 24Nov 24
ZEO PE Ratio by quarter
PeriodPE Ratio
Nov 2412.84
Nov 2411.86
Nov 2411.76
Nov 2413.72
Oct 2412.84
Oct 2413.33
Oct 2415.78
Oct 2417.35
Sep 2420.68
Sep 2427.35
Sep 2417.15
Sep 2418.82
Aug 2418.62
Aug 2415.95
Aug 2418.95
Aug 2423.02
Aug 2423.77
Jul 2422.58
Jul 2421.52
Jul 2419.39
Jul 2415.01
Jun 2413.45
Jun 2422.77
Jun 2428.83
Jun 2428.21
May 2429.15
May 2413.36
May 2413.47
May 2413.74
May 2413.47
Apr 2413.03
Apr 2413.72
Apr 2414.81
Apr 2415.36
Mar 2415.64
Mar 2417.23
Mar 2417.78
Mar 2419.07
Mar 2417.04
Feb 2412.32
Feb 2412.24
Feb 2412.17
Feb 2412.15
Jan 2412.22
Jan 2412.13
Jan 2412.09
Jan 2412.08
Dec 2312.07
Dec 2312.07
Dec 2312.06
Dec 2312.07
Dec 2312.07
Nov 238.65
Nov 238.72
Nov 238.68
Nov 238.66
Oct 238.62
Oct 238.73
Oct 238.59
Oct 238.59
Sep 238.56
Sep 238.55
Sep 238.52
Sep 238.5
Sep 238.48
Aug 2313.2
Aug 2313.2
Aug 2313.1
Aug 2313.1
Jul 2313.16
Jul 2313.08
Jul 2313
Jul 2313
Jun 2313
Jun 2312.99
Jun 2312.99
Jun 2312.99
Jun 2312.85
May 2329.49
May 2329.47
May 2329.47
May 2329.47
Apr 2329.38
Apr 2329.27
Apr 2328.89
Apr 2328.86
Mar 2328.86
Mar 2328.86
Mar 2328.86
Mar 2328.72
Mar 2328.72
Free Cash Flow Yield
-150%-100%-50%0%med -30.58%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
ZEO Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-105.08%
Sep 26-105.97%
Sep 26-103.19%
Aug 26-89.92%
Aug 26-62.17%
Aug 26-40.73%
Aug 26-57.55%
Jul 26-66.79%
Jul 26-61.91%
Jul 26-61.8%
Jul 26-51.9%
Jul 26-50.2%
Jun 26-52.25%
Jun 26-46.77%
Jun 26-43.01%
Jun 26-40.74%
May 26-39.48%
May 26-39.32%
May 26-37.69%
May 26-44.65%
May 26-43.22%
Apr 26-43.42%
Apr 26-59.41%
Apr 26-72.54%
Apr 26-62.68%
Mar 26-53.97%
Mar 26-39.29%
Mar 26-33.81%
Mar 26-34.09%
Feb 26-26.18%
Feb 26-24.77%
Feb 26-32.85%
Feb 26-34.49%
Jan 26-33.51%
Jan 26-31.26%
Jan 26-30.96%
Jan 26-30.09%
Jan 26-27.52%
Dec 25-34.47%
Dec 25-32.86%
Dec 25-29.27%
Dec 25-25.55%
Nov 25-21.46%
Nov 25-24.03%
Nov 25-21.32%
Nov 25-5.86%
Oct 25-4.55%
Oct 25-4.06%
Oct 25-5.07%
Oct 25-6.13%
Oct 25-6.18%
Sep 25-5.77%
Sep 25-6.58%
Sep 25-6.13%
Sep 25-5.94%
Aug 25-4.83%
Aug 25-3.78%
Aug 25-3.51%
Aug 25-4.37%
Aug 25-4.12%
Jul 25-3.95%
Jul 25-4.07%
Jul 25-4.02%
Jul 25-3.63%
Jun 25-3.36%
Jun 25-3.62%
Jun 25-24.17%
Jun 25-30.21%
May 25-26.59%
May 25-36.01%
May 25-36.7%
May 25-34.28%
May 25-33.09%
Apr 25-33.68%
Apr 25-32.71%
Apr 25-41.19%
Apr 25-37.18%
Mar 25-35.34%
Mar 25-33.09%
Mar 25-35.78%
Mar 25-35.78%
Feb 25-27.52%
Feb 25-25.44%
Feb 25-26.5%
Feb 25-22.99%
Jan 25-20.97%
Jan 25-19.54%
Jan 25-17.35%
Jan 25-26.38%
Jan 25-16.69%
Dec 24-19.88%
Dec 24-28.06%
Dec 24-22.54%
Dec 24-42.41%
Nov 24-44.38%
Nov 24-19.47%
Nov 24-21.08%
Nov 24-21.26%
Nov 24-18.22%
Oct 24-19.47%
Price to Sales
00.20.40.60.8med 0.33Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
ZEO Price to Sales by quarter
PeriodPrice to Sales
Sep 260.08
Sep 260.08
Sep 260.08
Aug 260.1
Aug 260.14
Aug 260.21
Aug 260.2
Jul 260.17
Jul 260.18
Jul 260.18
Jul 260.22
Jul 260.23
Jun 260.22
Jun 260.24
Jun 260.26
Jun 260.28
May 260.29
May 260.29
May 260.3
May 260.32
May 260.33
Apr 260.33
Apr 260.24
Apr 260.2
Apr 260.23
Mar 260.23
Mar 260.32
Mar 260.37
Mar 260.37
Feb 260.48
Feb 260.51
Feb 260.39
Feb 260.37
Jan 260.38
Jan 260.41
Jan 260.41
Jan 260.42
Jan 260.46
Dec 250.37
Dec 250.39
Dec 250.43
Dec 250.5
Nov 250.59
Nov 250.53
Nov 250.59
Nov 250.46
Oct 250.59
Oct 250.66
Oct 250.53
Oct 250.44
Oct 250.44
Sep 250.47
Sep 250.41
Sep 250.44
Sep 250.45
Aug 250.56
Aug 250.72
Aug 250.77
Aug 250.5
Aug 250.53
Jul 250.55
Jul 250.53
Jul 250.54
Jul 250.6
Jun 250.65
Jun 250.6
Jun 250.51
Jun 250.41
May 250.47
May 250.22
May 250.22
May 250.23
May 250.24
Apr 250.24
Apr 250.25
Apr 250.2
Apr 250.22
Mar 250.23
Mar 250.24
Mar 250.22
Mar 250.22
Feb 250.29
Feb 250.32
Feb 250.3
Feb 250.35
Jan 250.38
Jan 250.41
Jan 250.46
Jan 250.3
Jan 250.48
Dec 240.4
Dec 240.29
Dec 240.36
Dec 240.19
Nov 240.18
Nov 240.15
Nov 240.14
Nov 240.14
Nov 240.16
Oct 240.15
EV/EBITDA
01020304050med 9.31Apr 23Jun 23Sep 23Dec 23Mar 24May 24Aug 24
ZEO EV/EBITDA by quarter
PeriodEV/EBITDA
Aug 2422.24
Aug 2427.35
Aug 2434.27
Aug 2435.55
Jul 2433.52
Jul 2431.72
Jul 2428.1
Jul 2420.64
Jun 2417.98
Jun 2433.84
Jun 2444.17
Jun 2443.11
May 2444.7
May 245.66
May 245.71
May 245.84
May 245.71
Apr 245.5
Apr 245.83
Apr 246.35
Apr 246.62
Mar 246.75
Mar 247.51
Mar 247.77
Mar 248.39
Mar 247.42
Feb 248.49
Feb 248.43
Feb 248.38
Feb 248.37
Jan 248.41
Jan 248.35
Jan 248.32
Jan 248.31
Dec 238.31
Dec 238.31
Dec 238.3
Dec 238.31
Dec 238.31
Nov 236.78
Nov 236.82
Nov 236.79
Nov 236.78
Oct 236.75
Oct 236.84
Oct 236.73
Oct 236.72
Sep 236.7
Sep 236.69
Sep 236.67
Sep 236.66
Sep 236.64
Aug 2310.4
Aug 2310.4
Aug 2310.32
Aug 2310.32
Jul 2310.37
Jul 2310.31
Jul 2310.24
Jul 2310.24
Jun 2310.24
Jun 2310.24
Jun 2310.24
Jun 2310.24
Jun 2310.12
May 2325.9
May 2325.87
May 2325.87
May 2325.87
Apr 2325.8
Apr 2325.7
Apr 2325.36
Apr 2325.34
Mar 2325.34
Mar 2325.34
Mar 2325.34
Mar 2325.22
Mar 2325.22
Price/Operating Cashflow
0200400600800med 51.92Apr 23Jun 23Sep 23Dec 23Mar 24May 24Aug 24
ZEO Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Aug 2476.46
Aug 2490.86
Aug 24110.35
Aug 24113.95
Jul 24108.25
Jul 24103.15
Jul 2492.96
Jul 2471.97
Jun 2464.47
Jun 24109.15
Jun 24138.24
Jun 24135.24
May 24139.73
May 243.62
May 243.65
May 243.73
May 243.65
Apr 243.53
Apr 243.72
Apr 244.02
Apr 244.16
Mar 244.24
Mar 244.67
Mar 244.82
Mar 245.17
Mar 244.62
Feb 2416.87
Feb 2416.76
Feb 2416.67
Feb 2416.64
Jan 2416.73
Jan 2416.61
Jan 2416.55
Jan 2416.54
Dec 2316.52
Dec 2316.52
Dec 2316.51
Dec 2316.52
Dec 2316.52
Nov 2339.02
Nov 2339.3
Nov 2339.12
Nov 2339.06
Oct 2338.85
Oct 2339.37
Oct 2338.74
Oct 2338.71
Sep 2338.61
Sep 2338.54
Sep 2338.43
Sep 2338.33
Sep 2338.22
Aug 2371.09
Aug 2371.09
Aug 2370.51
Aug 2370.51
Jul 2370.84
Jul 2370.45
Jul 2370
Jul 2370
Jun 2370
Jun 2369.93
Jun 2369.93
Jun 2369.93
Jun 2369.16
May 23641.95
May 23641.35
May 23641.35
May 23641.35
Apr 23639.56
Apr 23637.16
Apr 23628.79
Apr 23628.19
Mar 23628.19
Mar 23628.19
Mar 23628.19
Mar 23625.2
Mar 23625.2
Price to Book
01234med 0.84Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
ZEO Price to Book by quarter
PeriodPrice to Book
Sep 260.64
Sep 260.64
Sep 260.66
Aug 260.75
Aug 261.09
Aug 261.66
Aug 260.33
Jul 260.29
Jul 260.31
Jul 260.31
Jul 260.37
Jul 260.38
Jun 260.37
Jun 260.41
Jun 260.45
Jun 260.47
May 260.49
May 260.49
May 260.51
May 260.73
May 260.76
Apr 260.75
Apr 260.55
Apr 260.45
Apr 260.52
Mar 260.35
Mar 260.49
Mar 260.56
Mar 260.56
Feb 260.73
Feb 260.77
Feb 260.58
Feb 260.55
Jan 260.57
Jan 260.61
Jan 260.62
Jan 260.63
Jan 260.69
Dec 250.55
Dec 250.58
Dec 250.65
Dec 250.75
Nov 250.89
Nov 250.79
Nov 250.89
Nov 252.31
Oct 252.98
Oct 253.33
Oct 252.67
Oct 252.21
Oct 252.19
Sep 252.35
Sep 252.06
Sep 252.21
Sep 252.28
Aug 252.81
Aug 253.59
Aug 253.86
Aug 252.05
Aug 252.17
Jul 252.27
Jul 252.2
Jul 252.22
Jul 252.46
Jun 252.66
Jun 252.47
Jun 250.88
Jun 250.7
May 250.8
May 250.98
May 250.96
May 251.03
May 251.07
Apr 251.05
Apr 251.08
Apr 250.86
Apr 250.95
Mar 251
Mar 251.07
Mar 250.99
Mar 250.99
Feb 251.28
Feb 251.39
Feb 251.33
Feb 251.53
Jan 251.68
Jan 251.8
Jan 252.03
Jan 251.34
Jan 252.11
Dec 241.77
Dec 241.26
Dec 241.56
Dec 240.83
Nov 240.79
Nov 240.39
Nov 240.36
Nov 240.35
Nov 240.41
Oct 240.39
Zeo Energy Corp.
ZEO
Stockpicker

Video analysis: ZEO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ZEO

ZEO ScientifiX Plans Expansion into Georgia and Tennessee as New Regenerative Medicine Laws Take Effect

accessnewswire.com · 15 Sep 2026

ZEO ScientifiX Plans Expansion into Georgia and Tennessee as New Regenerative Medicine Laws Take Effect

Company looks to broaden its Southeast presence to support healthcare providers navigating newly enacted state laws providing for certain stem cell and regenerative medicine therapies. FORT LAUDERDALE, FL AND DAVIE, FL / ACCESS Newswire / September 15, 2026 / ZEO ScientifiX, Inc. (OTCQB:ZEOX) ("ZEO ScientifiX" or the "Company") today announced its planned expansion into Georgia and Tennessee following the recent enactment by each state of new laws establishing frameworks for certain stem cell and regenerative medicine therapies.

Zeo Energy Selected as Fulcrum Point's Primary Energy Storage Provider for Power Development Projects

globenewswire.com · 8 Sep 2026

Zeo Energy Selected as Fulcrum Point's Primary Energy Storage Provider for Power Development Projects

In initial collaboration near Brigham City, Utah, Zeo will support Fulcrum's gas-fired power project Arrangement also creates potential for Zeo to access Fulcrum's gas development capabilities for select Zeo behind-the-meter projects NEW PORT RICHEY, Fla., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo,” “Zeo Energy,” or the “Company”), a provider of solar and energy storage solutions, today announced it has entered into a Co-Development and Collaboration Agreement ("Agreement") with Fulcrum Point Holdings, LLC ("Fulcrum"), an energy infrastructure development company developing gas, geothermal, and nuclear power projects in the Mountain West.

NewHold Investment Corp III (NASDAQ:NHIC) & Zeo Energy (NASDAQ:ZEO) Head-To-Head Analysis

defenseworld.net · 4 Sep 2026

NewHold Investment Corp III (NASDAQ:NHIC) & Zeo Energy (NASDAQ:ZEO) Head-To-Head Analysis

NewHold Investment Corp III (NASDAQ: NHIC - Get Free Report) and Zeo Energy (NASDAQ: ZEO - Get Free Report) are both small-cap industrials companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, institutional ownership, risk, dividends and earnings. Earnings and Valuation This table

Zeo Energy Corp. To Present at The Moody Capital Disruptive Growth & Life Sciences Conference on September 10, 2026

newsfilecorp.com · 1 Sep 2026

Zeo Energy Corp. To Present at The Moody Capital Disruptive Growth & Life Sciences Conference on September 10, 2026

New Port Richey, Florida--(Newsfile Corp. - September 1, 2026) - Zeo Energy Corp. (NASDAQ: ZEO) ("Zeo," "Zeo Energy," or the "Company"), a provider of residential solar and commercial long-duration energy-storage solutions, is confirmed to present at the Moody Capital Disruptive Growth & Life Sciences Conference, which is being held September 9-10 at The Westin New York Grand Central in New York, NY. Zeo's CEO, Tim Bridgewater is scheduled to present on Thursday, September 10th at 11:55 a.m.

ZEO ScientifiX Announces Multidisciplinary Expert Faculty Lineup for the ZEO Xperience

accessnewswire.com · 1 Sep 2026

ZEO ScientifiX Announces Multidisciplinary Expert Faculty Lineup for the ZEO Xperience

Leading physicians, scientists, regulatory experts, and healthcare innovators will convene October 23-25 at Fort Lauderdale's Pier Sixty-Six Resort + Marina for three days of regenerative medicine education, hands-on clinical training, and interdisciplinary collaboration FORT LAUDERDALE, FL / ACCESS Newswire / September 1, 2026 / ZEO ScientifiX, Inc. (OTCQB:ZEOX) ("ZEO ScientifiX" or the "Company") today announced the multidisciplinary faculty and guest speaker lineup for the inaugural ZEO Xperience, a three-day immersive regenerative medicine event for healthcare professionals taking place October 23-25, 2026, at Pier Sixty-Six Resort + Marina in Fort Lauderdale, Florida. Bringing together physicians, scientists, regulatory professionals, clinical educators, and healthcare innovators from across the country, the ZEO Xperience is designed to create a setting where healthcare professionals can explore regenerative medicine from multiple perspectives, including the underlying science and manufacturing of biologics, the current regulatory landscape, current clinical best practices for a variety of applications, and practice implementation.

Zeo Stock Falls 49.5% Despite Reporting Narrower Y/Y Loss in Q2

zacks.com · 27 Aug 2026

Zeo Stock Falls 49.5% Despite Reporting Narrower Y/Y Loss in Q2

ZEO's Q2 revenues decline y/y on fewer solar installations, while higher labor and domestic-content material costs compress the gross margin.

Zeo Energy Reports Second Quarter 2026 Financial Results

globenewswire.com · 14 Aug 2026

Zeo Energy Reports Second Quarter 2026 Financial Results

1H 2026 revenue increased 9.2% Continued focus on identifying accretive commercial opportunities and controlling costs NEW PORT RICHEY, Fla., Aug. 14, 2026 (GLOBE NEWSWIRE) --   Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo,” “Zeo Energy,” or the “Company”), a provider of residential solar and commercial long-duration energy-storage solutions, today reported financial results for the second quarter and first half ended June 30, 2026.

ZEO ScientifiX Launches First-of-Its-Kind ZEO Xperience, a Three-Day Immersive Regenerative Medicine Experience for Healthcare Professionals

accessnewswire.com · 4 Aug 2026

ZEO ScientifiX Launches First-of-Its-Kind ZEO Xperience, a Three-Day Immersive Regenerative Medicine Experience for Healthcare Professionals

Hosted at Fort Lauderdale's newly reimagined Pier Sixty-Six Resort, the inaugural event combines cutting-edge biologics education, hands-on clinical training, practice growth strategies, and latest innovations. FORT LAUDERDALE, FL / ACCESS Newswire / August 4, 2026 / ZEO ScientifiX, Inc. (OTCQB:ZEOX) ("ZEO ScientifiX" or the "Company"), a biologics research and products company advancing regenerative medicine, physician education, and next-generation biologic technologies, today announced the launch of ZEO Xperience, the Company's inaugural three-day immersive educational experience designed exclusively for healthcare professionals seeking to expand their knowledge of regenerative biologics, strengthen clinical expertise, and learn best practices for responsibly integrating advanced biologic therapies into patient care.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.